Key result
Higher preoperative HDL linked to ~66% lower mid-term mortality after rheumatic mitral valve surgery.
Why the study?
Rheumatic heart disease often leads to severe leaflet calcification, but the causes of calcification and factors influencing surgical prognosis are not clearly understood.
Does a higher preoperative HDL level improve mid-term survival and reduce major adverse cardiovascular events in patients undergoing mitral valve surgery for rheumatic heart disease?
Cohort (n=847)
No
Does a higher preoperative HDL level improve mid-term survival and reduce major adverse cardiovascular events in patients undergoing mitral valve surgery for rheumatic heart disease?
Higher preoperative HDL levels are associated with significantly lighter mitral valve calcification, improved mid-term survival, and a lower risk of MACE in patients undergoing mitral valve surgery for rheumatic heart disease.
Answers are grounded in this paper and cite their sources.
Should not yet change preoperative risk assessment; hypothesis-generating for HDL links to reduced calcification and MACE after rheumatic valve surgery.
BACKGROUND: Rheumatic heart disease remains the most common valvular heart disease in Asia and often leads to severe calcification of the valve leaflets. However, the causes of calcification and the factors influencing the prognosis of surgical patients are not yet clearly understood. OBJECTIVES: This study aimed to explore the impact of plasma high-density lipoprotein (HDL) levels on the formation of rheumatic mitral valve calcification and the surgical prognosis. METHODS: This retrospective cohort study included 847 patients who underwent mitral valve surgery for rheumatic heart disease at the Beijing Anzhen Hospital from January 2016 to December 2022. Patients were divided into a high HDL group (n = 413) and a low HDL group (n = 434) based on preoperative HDL levels. RESULTS: Among 847 surgical patients (median follow-up 44.1 months), Kaplan-Meier analysis revealed that the high HDL group had higher mid-term survival (P = 0.018) and lower major adverse cardiovascular events risk (P = 0.005). Multivariate Cox regression confirmed HDL as independent risk factor for major adverse cardiovascular events (HR: 0.370; 95% CI: 0.220-0.620; P < 0.001), whereas other traditional lipid markers, including low-density lipoprotein (HR: 0.82; 95% CI: 0.54-1.23; P = 0.328) and triglycerides (HR: 0.65; 95% CI: 0.38-1.10; P = 0.107), were not statistically significant. Logistic regression indicated HDL as a protective factor against mitral valve calcification (HR: 0.01; 95% CI: 0.000-0.300; P = 0.009). Restricted cubic splines indicated that Agatston scores decreased with rising HDL when <1.3 mmol/L (P for nonlinear = 0.05; P for overall = 0.014). CONCLUSIONS: The findings suggest that higher preoperative HDL levels could be correlated with lighter valve calcification, enhanced mid-term survival rates, and a decreased risk of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a cohort in Rheumatic heart disease (n=847). High preoperative high-density lipoprotein (HDL) levels vs. Low preoperative HDL levels was evaluated on Mid-term all-cause mortality (HR 0.340, 95% CI 0.159-0.729, p=0.006). Higher preoperative HDL levels were independently associated with a lower risk of mid-term mortality and a reduced severity of mitral valve calcification in patients undergoing rheumatic mitral valve surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: